Report Detail
Global Leukemia Therapeutics Market Professional Survey Report 2019
- RnM3741705 |
- 12 September, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Leukemia is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells.
The global Leukemia Therapeutics market was valued at 10100 million US$ in 2018 and will reach 13700 million US$ by the end of 2025, growing at a CAGR of 3.8% during 2019-2025.
This report focuses on Leukemia Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leukemia Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Leukemia Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Leukemia Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche
GlaxoSmithKline
Novartis
Bristol-Myers Squibb
Eisai
Biogen Idec
ERYtech Pharma
Celgene
Genmab
Cephalon
Clavis Pharma
Pfizer
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Gleevec
Sprycel
Tasigna
Clolar
Others
Segment by Application
Hospital
Clinic
Table of Contents
Executive Summary
1 Industry Overview of Leukemia Therapeutics
- 1.1 Definition of Leukemia Therapeutics
- 1.2 Leukemia Therapeutics Segment by Type
- 1.2.1 Global Leukemia Therapeutics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Gleevec
- 1.2.3 Sprycel
- 1.2.4 Tasigna
- 1.2.5 Clolar
- 1.2.6 Others
- 1.3 Leukemia Therapeutics Segment by Applications
- 1.3.1 Global Leukemia Therapeutics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Global Leukemia Therapeutics Overall Market
- 1.4.1 Global Leukemia Therapeutics Revenue (2014-2025)
- 1.4.2 Global Leukemia Therapeutics Production (2014-2025)
- 1.4.3 North America Leukemia Therapeutics Status and Prospect (2014-2025)
- 1.4.4 Europe Leukemia Therapeutics Status and Prospect (2014-2025)
- 1.4.5 China Leukemia Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Japan Leukemia Therapeutics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Leukemia Therapeutics Status and Prospect (2014-2025)
- 1.4.8 India Leukemia Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Leukemia Therapeutics
- 2.3 Manufacturing Process Analysis of Leukemia Therapeutics
- 2.4 Industry Chain Structure of Leukemia Therapeutics
3 Development and Manufacturing Plants Analysis of Leukemia Therapeutics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Leukemia Therapeutics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Leukemia Therapeutics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Leukemia Therapeutics Production and Capacity Analysis
- 4.2 Leukemia Therapeutics Revenue Analysis
- 4.3 Leukemia Therapeutics Price Analysis
- 4.4 Market Concentration Degree
5 Leukemia Therapeutics Regional Market Analysis
- 5.1 Leukemia Therapeutics Production by Regions
- 5.1.1 Global Leukemia Therapeutics Production by Regions
- 5.1.2 Global Leukemia Therapeutics Revenue by Regions
- 5.2 Leukemia Therapeutics Consumption by Regions
- 5.3 North America Leukemia Therapeutics Market Analysis
- 5.3.1 North America Leukemia Therapeutics Production
- 5.3.2 North America Leukemia Therapeutics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Leukemia Therapeutics Import and Export
- 5.4 Europe Leukemia Therapeutics Market Analysis
- 5.4.1 Europe Leukemia Therapeutics Production
- 5.4.2 Europe Leukemia Therapeutics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Leukemia Therapeutics Import and Export
- 5.5 China Leukemia Therapeutics Market Analysis
- 5.5.1 China Leukemia Therapeutics Production
- 5.5.2 China Leukemia Therapeutics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Leukemia Therapeutics Import and Export
- 5.6 Japan Leukemia Therapeutics Market Analysis
- 5.6.1 Japan Leukemia Therapeutics Production
- 5.6.2 Japan Leukemia Therapeutics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Leukemia Therapeutics Import and Export
- 5.7 Southeast Asia Leukemia Therapeutics Market Analysis
- 5.7.1 Southeast Asia Leukemia Therapeutics Production
- 5.7.2 Southeast Asia Leukemia Therapeutics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Leukemia Therapeutics Import and Export
- 5.8 India Leukemia Therapeutics Market Analysis
- 5.8.1 India Leukemia Therapeutics Production
- 5.8.2 India Leukemia Therapeutics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Leukemia Therapeutics Import and Export
6 Leukemia Therapeutics Segment Market Analysis (by Type)
- 6.1 Global Leukemia Therapeutics Production by Type
- 6.2 Global Leukemia Therapeutics Revenue by Type
- 6.3 Leukemia Therapeutics Price by Type
7 Leukemia Therapeutics Segment Market Analysis (by Application)
- 7.1 Global Leukemia Therapeutics Consumption by Application
- 7.2 Global Leukemia Therapeutics Consumption Market Share by Application (2014-2019)
8 Leukemia Therapeutics Major Manufacturers Analysis
- 8.1 Roche
- 8.1.1 Roche Leukemia Therapeutics Production Sites and Area Served
- 8.1.2 Roche Product Introduction, Application and Specification
- 8.1.3 Roche Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 GlaxoSmithKline
- 8.2.1 GlaxoSmithKline Leukemia Therapeutics Production Sites and Area Served
- 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.2.3 GlaxoSmithKline Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Novartis
- 8.3.1 Novartis Leukemia Therapeutics Production Sites and Area Served
- 8.3.2 Novartis Product Introduction, Application and Specification
- 8.3.3 Novartis Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Bristol-Myers Squibb
- 8.4.1 Bristol-Myers Squibb Leukemia Therapeutics Production Sites and Area Served
- 8.4.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.4.3 Bristol-Myers Squibb Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Eisai
- 8.5.1 Eisai Leukemia Therapeutics Production Sites and Area Served
- 8.5.2 Eisai Product Introduction, Application and Specification
- 8.5.3 Eisai Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Biogen Idec
- 8.6.1 Biogen Idec Leukemia Therapeutics Production Sites and Area Served
- 8.6.2 Biogen Idec Product Introduction, Application and Specification
- 8.6.3 Biogen Idec Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 ERYtech Pharma
- 8.7.1 ERYtech Pharma Leukemia Therapeutics Production Sites and Area Served
- 8.7.2 ERYtech Pharma Product Introduction, Application and Specification
- 8.7.3 ERYtech Pharma Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Celgene
- 8.8.1 Celgene Leukemia Therapeutics Production Sites and Area Served
- 8.8.2 Celgene Product Introduction, Application and Specification
- 8.8.3 Celgene Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Genmab
- 8.9.1 Genmab Leukemia Therapeutics Production Sites and Area Served
- 8.9.2 Genmab Product Introduction, Application and Specification
- 8.9.3 Genmab Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Cephalon
- 8.10.1 Cephalon Leukemia Therapeutics Production Sites and Area Served
- 8.10.2 Cephalon Product Introduction, Application and Specification
- 8.10.3 Cephalon Leukemia Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Clavis Pharma
- 8.12 Pfizer
9 Development Trend of Analysis of Leukemia Therapeutics Market
- 9.1 Global Leukemia Therapeutics Market Trend Analysis
- 9.1.1 Global Leukemia Therapeutics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Leukemia Therapeutics Regional Market Trend
- 9.2.1 North America Leukemia Therapeutics Forecast 2019-2025
- 9.2.2 Europe Leukemia Therapeutics Forecast 2019-2025
- 9.2.3 China Leukemia Therapeutics Forecast 2019-2025
- 9.2.4 Japan Leukemia Therapeutics Forecast 2019-2025
- 9.2.5 Southeast Asia Leukemia Therapeutics Forecast 2019-2025
- 9.2.6 India Leukemia Therapeutics Forecast 2019-2025
- 9.3 Leukemia Therapeutics Market Trend (Product Type)
- 9.4 Leukemia Therapeutics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Leukemia Therapeutics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Leukemia Therapeutics. Industry analysis & Market Report on Leukemia Therapeutics is a syndicated market report, published as Global Leukemia Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Leukemia Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
